These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27169446)

  • 61. Circulating exosomal microRNAs in acquired aplastic anemia and myelodysplastic syndromes.
    Giudice V; Banaszak LG; Gutierrez-Rodrigues F; Kajigaya S; Panjwani R; Ibanez MDPF; Rios O; Bleck CK; Stempinski ES; Raffo DQ; Townsley DM; Young NS
    Haematologica; 2018 Jul; 103(7):1150-1159. PubMed ID: 29674506
    [TBL] [Abstract][Full Text] [Related]  

  • 62.
    Abuhadra N; Mukherjee S; Al-Issa K; Adema V; Hirsch CM; Advani A; Przychodzen B; Makhoul A; Awada H; Maciejewski JP; Sekeres MA; Nazha A
    Leuk Lymphoma; 2019 Jun; 60(6):1587-1590. PubMed ID: 30618304
    [No Abstract]   [Full Text] [Related]  

  • 63. Dynamics of clonal evolution in myelodysplastic syndromes.
    Makishima H; Yoshizato T; Yoshida K; Sekeres MA; Radivoyevitch T; Suzuki H; Przychodzen B; Nagata Y; Meggendorfer M; Sanada M; Okuno Y; Hirsch C; Kuzmanovic T; Sato Y; Sato-Otsubo A; LaFramboise T; Hosono N; Shiraishi Y; Chiba K; Haferlach C; Kern W; Tanaka H; Shiozawa Y; Gómez-Seguí I; Husseinzadeh HD; Thota S; Guinta KM; Dienes B; Nakamaki T; Miyawaki S; Saunthararajah Y; Chiba S; Miyano S; Shih LY; Haferlach T; Ogawa S; Maciejewski JP
    Nat Genet; 2017 Feb; 49(2):204-212. PubMed ID: 27992414
    [TBL] [Abstract][Full Text] [Related]  

  • 64. STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients.
    Jerez A; Clemente MJ; Makishima H; Rajala H; Gómez-Seguí I; Olson T; McGraw K; Przychodzen B; Kulasekararaj A; Afable M; Husseinzadeh HD; Hosono N; LeBlanc F; Lagström S; Zhang D; Ellonen P; Tichelli A; Nissen C; Lichtin AE; Wodnar-Filipowicz A; Mufti GJ; List AF; Mustjoki S; Loughran TP; Maciejewski JP
    Blood; 2013 Oct; 122(14):2453-9. PubMed ID: 23926297
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome.
    Field JJ; Mason PJ; An P; Kasai Y; McLellan M; Jaeger S; Barnes YJ; King AA; Bessler M; Wilson DB
    J Pediatr Hematol Oncol; 2006 Jul; 28(7):450-3. PubMed ID: 16825992
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
    Volkert S; Kohlmann A; Schnittger S; Kern W; Haferlach T; Haferlach C
    Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia.
    Iwasaki T; Murakami M; Sugisaki C; Sobue S; Ohashi H; Asano H; Suzuki M; Nakamura S; Ito M; Murate T
    Pathol Int; 2008 Jun; 58(6):353-60. PubMed ID: 18477214
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Riddle: what do aplastic anemia, acute promyelocytic leukemia, and chronic myeloid leukemia have in common?
    Brodsky RA; Jones RJ
    Leukemia; 2004 Oct; 18(10):1740-2. PubMed ID: 15356647
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Utility of plasma cell-free DNA for
    Gutierrez-Rodrigues F; Beerman I; Groarke EM; Patel BA; Spitofsky N; Dillon LW; Raffo DQ; Hourigan CS; Kajigaya S; Ferrucci L; Young NS
    Haematologica; 2022 Aug; 107(8):1815-1826. PubMed ID: 34587721
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Transformation of severe aplastic anemia to myelodysplastic syndrome with monosomy 7 in a patient who achieved transfusion independence after immunosuppressive therapy].
    Takai K; Sanada M
    Rinsho Ketsueki; 2000 Apr; 41(4):347-53. PubMed ID: 10846467
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.
    Socié G; Henry-Amar M; Bacigalupo A; Hows J; Tichelli A; Ljungman P; McCann SR; Frickhofen N; Van't Veer-Korthof E; Gluckman E
    N Engl J Med; 1993 Oct; 329(16):1152-7. PubMed ID: 8377778
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pediatric aplastic anemia and refractory cytopenia: A retrospective analysis assessing outcomes and histomorphologic predictors.
    Forester CM; Sartain SE; Guo D; Harris MH; Weinberg OK; Fleming MD; London WB; Williams DA; Hofmann I
    Am J Hematol; 2015 Apr; 90(4):320-6. PubMed ID: 25580823
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Genetic characterization of acquired aplastic anemia by targeted sequencing.
    Heuser M; Schlarmann C; Dobbernack V; Panagiota V; Wiehlmann L; Walter C; Beier F; Ziegler P; Yun H; Kade S; Kirchner A; Huang L; Koenecke C; Eder M; Brümmendorf TH; Dugas M; Ganser A; Thol F
    Haematologica; 2014 Sep; 99(9):e165-7. PubMed ID: 24907358
    [No Abstract]   [Full Text] [Related]  

  • 74. Acquired aplastic anemia: correlation between etiology, pathophysiology, bone marrow histology and prognosis factors.
    Găman A; Găman G; Bold A
    Rom J Morphol Embryol; 2009; 50(4):669-74. PubMed ID: 19942964
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia.
    Zaimoku Y; Patel BA; Adams SD; Shalhoub R; Groarke EM; Lee AAC; Kajigaya S; Feng X; Rios OJ; Eager H; Alemu L; Quinones Raffo D; Wu CO; Flegel WA; Young NS
    Blood; 2021 Dec; 138(26):2799-2809. PubMed ID: 34724566
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical implications of somatic mutations in aplastic anemia and myelodysplastic syndrome in genomic age.
    Maciejewski JP; Balasubramanian SK
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):66-72. PubMed ID: 29222238
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: a single-center experience.
    Li Y; Li X; Ge M; Shi J; Qian L; Zheng Y; Wang J
    Ann Hematol; 2011 May; 90(5):529-37. PubMed ID: 21207031
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
    Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
    Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes.
    Devillier R; Mansat-De Mas V; Gelsi-Boyer V; Demur C; Murati A; Corre J; Prebet T; Bertoli S; Brecqueville M; Arnoulet C; Recher C; Vey N; Mozziconacci MJ; Delabesse E; Birnbaum D
    Oncotarget; 2015 Apr; 6(10):8388-96. PubMed ID: 25860933
    [TBL] [Abstract][Full Text] [Related]  

  • 80. High frequency of several PIG-A mutations in patients with aplastic anemia and myelodysplastic syndrome.
    Okamoto M; Shichishima T; Noji H; Ikeda K; Nakamura A; Akutsu K; Maruyama Y
    Leukemia; 2006 Apr; 20(4):627-34. PubMed ID: 16467865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.